Avanos Medical (NYSE:AVNS) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Avanos Medical (NYSE:AVNS) announced its quarterly earnings data on Wednesday. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03, Zacks reports. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical updated its FY 2025 guidance to 1.050-1.250 EPS.

Avanos Medical Stock Up 2.9 %

AVNS traded up $0.45 on Wednesday, hitting $16.01. The company had a trading volume of 407,496 shares, compared to its average volume of 535,439. The stock has a fifty day moving average price of $16.15 and a 200-day moving average price of $19.73. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical has a 12-month low of $14.40 and a 12-month high of $25.36. The stock has a market capitalization of $735.96 million, a price-to-earnings ratio of 47.54 and a beta of 0.98.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.